{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T04:57:18Z","timestamp":1771390638346,"version":"3.50.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.1002\/ejhf.70055","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T17:39:10Z","timestamp":1758130750000},"page":"2855-2857","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucagon-Like Peptide-1 Receptor Agonists Across the Cardiovascular-Kidney-Metabolic Spectrum: One Size Does not Fit All"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"first","affiliation":[{"name":"RISE-Health, Department of Surgery and Physiology, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]},{"name":"Universit\u00e9 de Lorraine, Inserm, Centre d'Investigations Cliniques - Plurith\u00e9matique 14-33, and Inserm U1116, CHRU Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) , Nancy ,","place":["France"]}]},{"given":"Pedro","family":"Marques","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Surgery and Physiology, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]}]},{"given":"Bernhard","family":"Haring","sequence":"additional","affiliation":[{"name":"HOMICAREM (HOMburg Institute of CArdioREnalMetabolic Medicine), Saarland University , Homburg ,","place":["Germany"]},{"name":"Department of Medicine IV, Clinic Hietzing, Vienna Healthcare Group , Vienna ,","place":["Austria"]}]},{"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Surgery and Physiology, Faculty of Medicine, University of Porto , Porto ,","place":["Portugal"]}]}],"member":"286","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"2026021721525639300_ejhf70055-bib-0001","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026021721525639300_ejhf70055-bib-0002","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/dom.14707","article-title":"Effect of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: A meta-analysis of placebo-controlled randomized trials","volume":"24","author":"Leite","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"2026021721525639300_ejhf70055-bib-0003","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(24)01643-X","article-title":"Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: A pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials","volume":"404","author":"Kosiborod","year":"2024","journal-title":"Lancet"},{"key":"2026021721525639300_ejhf70055-bib-0004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/dom.14862","article-title":"Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post-hoc analysis of the FIGHT trial","volume":"25","author":"Neves","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"2026021721525639300_ejhf70055-bib-0005","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: A prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"key":"2026021721525639300_ejhf70055-bib-0006","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jacc.2024.08.004","article-title":"Effects of semaglutide on heart failure outcomes in diabetes and chronic kidney disease in the FLOW trial","volume":"84","author":"Pratley","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026021721525639300_ejhf70055-bib-0007","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ejhf.3478","article-title":"Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trial","volume":"27","author":"Neves","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026021721525639300_ejhf70055-bib-0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.03.035","article-title":"GLP-1 receptor agonists in heart failure with reduced ejection fraction: Meta-analysis of randomized clinical trials","volume":"13","author":"Neves","year":"2025","journal-title":"JACC Heart Fail"},{"key":"2026021721525639300_ejhf70055-bib-0009","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/ejhf.70048","article-title":"Effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidity","volume":"27","author":"Siddiqi","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026021721525639300_ejhf70055-bib-0010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2024.06.026","article-title":"Should the SELECT trial make us comfortable using GLP-1 receptor agonists in HFrEF?","volume":"84","author":"Neves","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026021721525639300_ejhf70055-bib-0011","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/dom.14997","article-title":"Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta-analysis of randomized placebo-controlled outcome trials","volume":"25","author":"Ferreira","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"2026021721525639300_ejhf70055-bib-0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/clinem\/dgad398","article-title":"Glucagon-like peptide-1 receptor agonists across the spectrum of heart failure","volume":"109","author":"Ferreira","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026021721525639300_ejhf70055-bib-0013","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ejhf.1047","article-title":"Will long-acting glucagon-like peptide-1 analogues recapitulate our agonizing experience with cyclic AMP-dependent positive inotropic agents in heart failure?","volume":"20","author":"Packer","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026021721525639300_ejhf70055-bib-0014","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.98.12.1184","article-title":"Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials","volume":"98","author":"Lechat","year":"1998","journal-title":"Circulation"},{"key":"2026021721525639300_ejhf70055-bib-0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102573","article-title":"Effects of glucagon-like peptide 1 receptor agonist initiation in patients with heart failure with reduced ejection fraction and implantable cardiac devices","author":"Marques","year":"2025","journal-title":"JACC Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/12\/2855\/66836675\/eurjhf_27_12_2855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/12\/2855\/66836675\/eurjhf_27_12_2855.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T02:53:06Z","timestamp":1771383186000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/27\/12\/2855\/8470688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":15,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,9,17]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.70055","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"2025-09-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}